{
  "entities": [
    {
      "id": "E1",
      "type": "Target",
      "name": "dopaminergic neuron",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.9,
      "evidence": "dopaminergic neuron is central",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.95,
      "evidence": "plasma membrane transporter DAT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.95,
      "evidence": "vesicular transporter VMAT2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.95,
      "evidence": "amphetamine (AMPH)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.95,
      "evidence": "cocaine (COC)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increase dopamine in the synapse",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.85,
      "evidence": "increase dopamine in the synapse",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "rewarding actions",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.8,
      "evidence": "rewarding actions of these drugs",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "addictive actions",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.8,
      "evidence": "addictive actions of these drugs",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "drug abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.85,
      "evidence": "drugs of abuse",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "confidence": 0.85,
      "evidence": "addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Kirshner 1962",
      "attributes": {
        "year": 1962,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.9,
      "evidence": "In 1962, Kirshner showed",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro experimental",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.8,
      "evidence": "experiments established the first molecular link",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "reserpine",
      "attributes": {},
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.95,
      "evidence": "reserpine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "abbreviation": "AMPH"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.9,
      "evidence": "amphetamine [AMPH]",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "phenylephrine",
      "attributes": {},
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.9,
      "evidence": "phenylephrine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "ephedrine",
      "attributes": {},
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.9,
      "evidence": "ephedrine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "epinephrine",
      "attributes": {
        "isotope_label": "14C"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.85,
      "evidence": "14C-epinephrine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "monoamine uptake into storage vesicles",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.8,
      "evidence": "monoamine uptake into storage vesicles",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "block epinephrine uptake",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.75,
      "evidence": "block 14C-epinephrine uptake",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "psychotropic drug action",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "confidence": 0.7,
      "evidence": "psychotropic drug action",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.9,
      "evidence": "VMAT1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "monoamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.85,
      "evidence": "monoamine transporter",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Slc18a1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.8,
      "evidence": "Slc18a1 (VMAT1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Slc18a2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.8,
      "evidence": "Slc18a2 (VMAT2)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "TEXANs",
      "attributes": {
        "target_type": "protein superfamily"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.75,
      "evidence": "TEXANs, for toxin-extruding antiporters",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "vesicular neurotransmitter transporters",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.8,
      "evidence": "vesicular neurotransmitter transporters",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "b4d52db84b5fecaea55a5d69dd4247fd"
      ],
      "confidence": 0.85,
      "evidence": "dopamine",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 knockout mice",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "confidence": 0.9,
      "evidence": "human variants in VMAT1",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "confidence": 0.9,
      "evidence": "linked to susceptibility for schizophrenia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "bipolar depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "confidence": 0.9,
      "evidence": "bipolar depression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "alcohol neurotoxicity",
      "attributes": {
        "condition_type": "condition"
      },
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "confidence": 0.85,
      "evidence": "protection from alcohol neurotoxicity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 binding sites in the brain",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "dihydrotetrabenazine",
      "attributes": {},
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "confidence": 0.9,
      "evidence": "PET ligand dihydrotetrabenazine, DTBZ",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "confidence": 0.85,
      "evidence": "treatment of addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 5
      },
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "confidence": 0.8,
      "evidence": "subjects of this review",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.9,
      "evidence": "VMAT1 and VMAT2 are co-expressed",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.95,
      "evidence": "primary emphasis on VMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "adrenal medulla",
      "attributes": {
        "target_type": "tissue"
      },
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.8,
      "evidence": "human adrenal medulla",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "peripheral adrenaline release",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.75,
      "evidence": "peripheral adrenaline release by drugs",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Hansson et al.",
      "attributes": {},
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.85,
      "evidence": "Hansson et al. have reported",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "mRNA expression evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "confidence": 0.7,
      "evidence": "VMAT1 mRNA expression",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.95,
      "evidence": "VMAT1 is present in human brain tissue",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 knockout mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.85,
      "evidence": "prevalence of schizophrenia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "affective disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.85,
      "evidence": "affective disorders",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Lohoff et al. study",
      "attributes": {
        "design": "observational"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.8,
      "evidence": "Lohoff et al. have also reported",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "review study",
      "attributes": {
        "design": "review"
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.75,
      "evidence": "For the purposes of this review",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vitro evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.7,
      "evidence": "studies have failed to substantiate",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "animal model evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "confidence": 0.8,
      "evidence": "VMAT2 knockout mice show",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is expressed in all monoaminergic neurons",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.9,
      "evidence": "dopamine (DA)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.9,
      "evidence": "serotonin (5-HT)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "norepinephrine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.9,
      "evidence": "norepinephrine (NE)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "epinephrine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.9,
      "evidence": "epinephrine (EPI)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "histamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.9,
      "evidence": "histamine (HIS)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "tyramine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.85,
      "evidence": "tyramine (TYR)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "phenylethylamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.85,
      "evidence": "phenylethylamine (PEA)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "5-HTT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "serotonergic plasma membrane transporter 5-HTT",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "dopamine plasma membrane transporter DAT",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "norepinephrine plasma membrane transporter NET",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "tyrosine hydroxylase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "tyrosine hydroxylase (TH)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "dopa decarboxylase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "dopa decarboxylase (AADC)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "dopamine beta-hydroxylase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "dopamine beta-hydroxylase (DBH)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "VACht",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d8c927406ec7feea0b99cd0158a4097b"
      ],
      "confidence": 0.8,
      "evidence": "vesicular acetylcholine transporter VACht",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.9,
      "evidence": "transition from recreational to compulsive drug use in addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "impairments in monoaminergic circuits",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.85,
      "evidence": "impairments in monoaminergic circuits in the CNS",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "neurotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.9,
      "evidence": "neurotoxicity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "enhanced sensitivity of receptor signaling",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.85,
      "evidence": "enhanced sensitivity of receptor signaling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 is likely to play a central role",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "depleted monoamine stores",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "confidence": 0.8,
      "evidence": "increasingly depleted monoamine stores",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is expressed",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HTT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "confidence": 0.9,
      "evidence": "These neurons also express 5-HTT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "confidence": 0.85,
      "evidence": "scavenge 5-HT from neighboring neurons",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "serotonergic neuron creation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "confidence": 0.7,
      "evidence": "create de novo \u201cserotonergic\u201d neurons",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "developmental effects of perinatal exposure to drugs of abuse",
      "attributes": {
        "condition_type": "developmental disorder",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "confidence": 0.65,
      "evidence": "developmental effects of perinatal exposure to drugs of abuse",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is the CNS vesicular transporter",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biogenic amines DA",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NE",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biogenic amines NE",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "EPI",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biogenic amines EPI",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biogenic amines 5-HT",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "HIS",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biogenic amines HIS",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "TYR",
      "attributes": {
        "target_type": "trace amine"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amines TYR",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PEA",
      "attributes": {
        "target_type": "trace amine"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amines PEA",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "THYR",
      "attributes": {
        "target_type": "trace amine"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "thyronamine (THYR)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "AADC",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "biosynthetic enzyme aromatic amino acid decarboxylase (AADC)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "TH",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.8,
      "evidence": "without TH",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "TAARs",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amine-associated receptors (TAARs)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amine reuptake transporters (i.e., DAT)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amine reuptake transporters (i.e., NET)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "5-HTT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.85,
      "evidence": "trace amine reuptake transporters (i.e., 5-HTT)",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "affected by AMPH",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "530104ab715e072d9b6f98681714e531"
      ],
      "confidence": 0.9,
      "evidence": "sensitization to COC",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "d-amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "d-amphetamine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "MDMA",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "MPP+",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "MPP+",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "dopamine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.9,
      "evidence": "5-HT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.8,
      "evidence": "COC",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Erickson et al. 32",
      "attributes": {
        "year": "32",
        "design": "heterologous-cell 5-HT uptake assay"
      },
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.85,
      "evidence": "Erickson et al. for human VMAT2",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vitro assay",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.8,
      "evidence": "heterologous-cell 5-HT uptake assay",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.85,
      "evidence": "addiction",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "hedonic reward",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "confidence": 0.75,
      "evidence": "hedonic reward",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "244ac784acafd50c3e222762b8344d1e"
      ],
      "confidence": 0.9,
      "evidence": "plasma membrane transporters DAT",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "244ac784acafd50c3e222762b8344d1e"
      ],
      "confidence": 0.9,
      "evidence": "plasma membrane transporters NET",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HTT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "244ac784acafd50c3e222762b8344d1e"
      ],
      "confidence": 0.9,
      "evidence": "plasma membrane transporters 5-HTT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "244ac784acafd50c3e222762b8344d1e"
      ],
      "confidence": 0.9,
      "evidence": "vesicular uptake mediated by VMAT2",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "244ac784acafd50c3e222762b8344d1e"
      ],
      "confidence": 0.7,
      "evidence": "investigated quite extensively",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.9,
      "evidence": "agents acting at VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.85,
      "evidence": "DAT/VMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.85,
      "evidence": "NET/VMAT2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HTT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.85,
      "evidence": "5-HTT/VMAT2",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.8,
      "evidence": "AMPH, COC or MDMA",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.8,
      "evidence": "AMPH, COC or MDMA",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {},
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.8,
      "evidence": "AMPH, COC or MDMA",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "vesicular amine depletion",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.75,
      "evidence": "Vesicular amine depletion",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "confidence": 0.7,
      "evidence": "individuals become addicted",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.9,
      "evidence": "VMAT isoform lacking the ability to store histamine (VMAT1)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "histamine",
      "attributes": {},
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.85,
      "evidence": "store histamine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.85,
      "evidence": "serotonin",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.8,
      "evidence": "AMPH",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "substance abuse and addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.9,
      "evidence": "substance abuse and addiction",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Duerr et al.",
      "attributes": {
        "year": "53"
      },
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.85,
      "evidence": "Duerr et al. have hypothesized",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "hypothesis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "confidence": 0.8,
      "evidence": "hypothesized",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "vesicular transporters",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.9,
      "evidence": "vesicular transporters as potential regulators",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VACht",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.95,
      "evidence": "vesicular acetylcholine transporter (VACht)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "ChAT",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.9,
      "evidence": "biosynthetic enzyme for acetylcholine, ChAT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "synaptic efficacy",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.85,
      "evidence": "Synaptic efficacy is thought to be the cellular substrate",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "learning and memory",
      "attributes": {
        "condition_type": "cognitive"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.8,
      "evidence": "cellular substrate for learning and memory",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.75,
      "evidence": "learning associated with addiction",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "activity-dependent changes in synaptic efficacy",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.8,
      "evidence": "activity-dependent changes in synaptic efficacy",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "changes in synaptic scaling",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.75,
      "evidence": "changes in synaptic scaling",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "altered vesicular (quantal) content",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.8,
      "evidence": "altered vesicular (quantal) content",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "dynamically regulated physiological process",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.7,
      "evidence": "neurotransmitter quantal content might be a dynamically regulated physiological process",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "affect quantal size",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.75,
      "evidence": "altered in vivo to affect quantal size",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "regulate the architecture of neurotransmission",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "confidence": 0.7,
      "evidence": "could regulate the architecture of neurotransmission",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "vesicular vacuolar H+-generating ATPase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.85,
      "evidence": "vesicular vacuolar H+-generating ATPase",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "THYR",
      "attributes": {},
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.8,
      "evidence": "thyroxine metabolite THYR",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Ueda laboratory study",
      "attributes": {
        "design": "experimental",
        "year": "implied from references"
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.7,
      "evidence": "Ueda laboratory has identified",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.75,
      "evidence": "injected into synaptosomes",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased quantal size",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.8,
      "evidence": "decreases quantal size",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "inhibition of monoamine uptake",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "confidence": 0.85,
      "evidence": "inhibitor of monoamine uptake",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 activity",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.9,
      "evidence": "VMAT1 or VMAT2 expression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "G-proteins",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.85,
      "evidence": "requires G-proteins",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Go",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "Go in platelets",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Gi",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "Gi in other cell types",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "CAPS",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "calcium-activated protein for secretion (CAPS)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.9,
      "evidence": "tritiated serotonin",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "biogenic amine",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.85,
      "evidence": "unlabeled biogenic amine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.9,
      "evidence": "cocaine (COC)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "METH",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.85,
      "evidence": "METH",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.85,
      "evidence": "AMPH",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "antidepressants",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "therapeutic agents such as antidepressants",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "vesicular filling",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.85,
      "evidence": "vesicular filling",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "regulation of quantal size",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "regulation of quantal size",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "behavioral sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.75,
      "evidence": "cocaine-induced behavioral sensitization",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Ahnert-Hilger et al. series",
      "attributes": {},
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.8,
      "evidence": "Ahnert-Hilger and colleagues in a series of papers",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "confidence": 0.7,
      "evidence": "VMAT1 or VMAT2 expression in CHO cells",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 transporter function",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PKA",
      "attributes": {
        "target_type": "signaling pathway"
      },
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "confidence": 0.85,
      "evidence": "PKA signaling is reduced",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "altered VMAT cellular trafficking",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "confidence": 0.8,
      "evidence": "altering VMAT cellular trafficking",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "VMAT2 trafficking to SSVs",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "confidence": 0.75,
      "evidence": "VMAT2 trafficking to SSVs",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.9,
      "evidence": "compounds targeting VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "lobaline",
      "attributes": {},
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.85,
      "evidence": "compounds targeting VMAT2, such as lobaline",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "methamphetamine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.9,
      "evidence": "treatment of methamphetamine addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cAMP/PKA signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.8,
      "evidence": "cAMP/PKA signaling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "VMAT phosphorylation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.8,
      "evidence": "VMAT phosphorylation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "G-protein-dependent alterations in vesicle filling",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.75,
      "evidence": "G-protein-dependent alterations in vesicle filling",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "transporter trafficking",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.75,
      "evidence": "transporter trafficking",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "confidence": 0.85,
      "evidence": "role if any in addiction itself",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "VMAT2 knockout mouse study (1997)",
      "attributes": {
        "year": 1997,
        "design": "knockout mouse model"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.9,
      "evidence": "In 1997, three groups independently reported the generation of knockout mice deficient in VMAT2 expression",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo knockout study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.85,
      "evidence": "knockout mice deficient in VMAT2 expression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 expression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.9,
      "evidence": "preservation of VMAT1",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "lethality at birth",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.85,
      "evidence": "Complete knockout (-/-) of VMAT2 expression is lethal at birth",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "lack of feeding behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.8,
      "evidence": "accompanied by lack of feeding behavior",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced monoamine accumulation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.8,
      "evidence": "reduced total labeled monoamine accumulation in whole brain vesicular membrane preparations",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "profoundly reduced monoamine levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.85,
      "evidence": "monoamine levels are profoundly reduced in VMAT2 (-/-) newborn mice",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.9,
      "evidence": "administration of amphetamine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "reserpine",
      "attributes": {},
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.85,
      "evidence": "levels found after reserpine administration",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.8,
      "evidence": "it is most likely dopamine-dependent",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.8,
      "evidence": "monoamine (5-HT, DA, and NE) levels",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {},
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "confidence": 0.8,
      "evidence": "monoamine (5-HT, DA, and NE) levels",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 heterozygous (+/-) mice",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "loss of endogenous DA and 5-HT",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.85,
      "evidence": "50% loss of endogenous DA and 5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "regulation of VMAT2 activity and/or expression",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.8,
      "evidence": "regulation of VMAT2 activity and/or expression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Pothos et al. (overexpression study)",
      "attributes": {
        "design": "overexpression in neuroendocrine cell models"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.75,
      "evidence": "Pothos and colleagues by overexpression of VMAT2",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.7,
      "evidence": "neuroendocrine cell models",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "quantal size is a direct function of vesicular VMAT2 density",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.8,
      "evidence": "quantal size is indeed a direct function",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "vesicular transport plays an important role in sequestration of neurotoxins",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.8,
      "evidence": "vesicular transport plays an important role",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "neurodegeneration",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.85,
      "evidence": "neurodegeneration and Parkinson-like clinical outcomes",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "Parkinson-like clinical outcomes",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.85,
      "evidence": "Parkinson-like clinical outcomes",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "altered sensitivity to locomotor effects of COC, AMPH, and alcohol",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "confidence": 0.8,
      "evidence": "altered sensitivity to the locomotor effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Uhl et al. study",
      "attributes": {
        "authors": "Uhl and colleagues",
        "year": null,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.85,
      "evidence": "Uhl and colleagues have reported",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.8,
      "evidence": "reported in VMAT2-deficient mice",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2-deficient mice",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "sensitization to AMPH-induced locomotion",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.8,
      "evidence": "sensitization to AMPH-induced locomotion",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "decreased AMPH-induced reward",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.8,
      "evidence": "decreased AMPH-induced reward",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "confidence": 0.85,
      "evidence": "AMPH-induced locomotion",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 in monoamine storage and release",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.9,
      "evidence": "Parkinson's disease",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.9,
      "evidence": "drug addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "environmental neurotoxin-mediated neurodegeneration",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.85,
      "evidence": "environmental neurotoxin-mediated neurodegeneration",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.9,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "bipolar disease",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.9,
      "evidence": "bipolar disease",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.9,
      "evidence": "schizophrenia",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "heritability evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.8,
      "evidence": "Heritability is taken as strong evidence",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "twin concordance evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.8,
      "evidence": "concordance in identical twins is taken as strong evidence",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "case-control association evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "confidence": 0.85,
      "evidence": "association between gene alleles and disease phenotypes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "affective disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.9,
      "evidence": "affective disorders",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.95,
      "evidence": "schizophrenia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "alcoholism",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.9,
      "evidence": "alcoholism",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "alcohol addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.85,
      "evidence": "alcohol addiction",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Uhl et al. (2000)",
      "attributes": {
        "year": 2000,
        "reference": "70"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.8,
      "evidence": "Uhl and coworkers essentially ruled out VMAT2 allelic variants",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Chu et al. (2000)",
      "attributes": {
        "year": 2000,
        "reference": "20"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.8,
      "evidence": "Chu and co-workers identify VMAT2 as one of nine genes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "mouse ethanol consumption study (2001)",
      "attributes": {
        "year": 2001,
        "reference": "71"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.75,
      "evidence": "ethanol consumption in male mice and VMAT2 expression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "VMAT2-deficient mice study (2002)",
      "attributes": {
        "year": 2002,
        "reference": "72"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.75,
      "evidence": "VMAT2-deficient mice show a decreased ethanol preference",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "hVMAT2 SNP study (2003)",
      "attributes": {
        "year": 2003,
        "reference": "21"
      },
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "confidence": 0.8,
      "evidence": "identification of an hVMAT2 SNP cluster",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Barr et al. (year not specified)",
      "attributes": {
        "design": "experimental study",
        "year": "not specified",
        "doi": "73"
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.8,
      "evidence": "work of Barr and colleagues",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.75,
      "evidence": "in infant rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 expression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "modulation of VMAT2 expression",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.85,
      "evidence": "modulation of VMAT2 expression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "corticosterone-dependent aversion learning",
      "attributes": {
        "condition_type": "behavioral process"
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.8,
      "evidence": "corticosterone-dependent aversion learning",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addictive behaviors",
      "attributes": {
        "condition_type": "behavioral disorder"
      },
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "confidence": 0.85,
      "evidence": "addictive behaviors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "dihydrotetrabenazine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.9,
      "evidence": "dihydrotetrabenazine (DTBZ)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 binding studies",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "tetrabenazine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.95,
      "evidence": "tetrabenazine (TBZ)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Product",
      "name": "Xenazine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.9,
      "evidence": "marketed under the trade name Xenazine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.85,
      "evidence": "chorea associated with Huntington's disease",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Tourette's syndrome",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.85,
      "evidence": "Tourette's syndrome",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.8,
      "evidence": "dopamine-depleting properties",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "reserpine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.85,
      "evidence": "reserpine (RES)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.7,
      "evidence": "NE",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "confidence": 0.7,
      "evidence": "5-HT",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "TBZ",
      "attributes": {},
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.95,
      "evidence": "TBZ does not bind to hVMAT1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "hVMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.9,
      "evidence": "TBZ does not bind to hVMAT1",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "hVMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.9,
      "evidence": "high affinity for hVMAT2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.85,
      "evidence": "TBZ binding to the tenth transmembrane domain of VMAT2",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "DA",
      "attributes": {},
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.8,
      "evidence": "high affinity for VMAT2 relative to DA",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic AMPH usage",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "confidence": 0.7,
      "evidence": "chronic AMPH usage",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "[11C]-DTBZ",
      "attributes": {},
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.95,
      "evidence": "[11C]-DTBZ",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.9,
      "evidence": "Parkinson's disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "Huntington's chorea",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.9,
      "evidence": "Huntington's chorea",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.9,
      "evidence": "Alzheimer's disease",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Boileau et al. study",
      "attributes": {
        "design": "human study"
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.8,
      "evidence": "Boileau et al. used human subjects",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "pre-clinical and clinical PET studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "confidence": 0.85,
      "evidence": "pre-clinical and clinical PET studies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter",
        "gene_symbol": "Slc18A2"
      },
      "source_chunk_ids": [
        "ac752596e0bb0cfb0fabeca7df869061"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is now the accepted name",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter",
        "gene_symbol": "Slc18A1"
      },
      "source_chunk_ids": [
        "ac752596e0bb0cfb0fabeca7df869061"
      ],
      "confidence": 0.9,
      "evidence": "VMAT1 is the accepted name",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Kilbourn et al. rat study",
      "attributes": {
        "design": "systematic study",
        "species": "rat"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.85,
      "evidence": "Kilbourn et al. conducted a more systematic study in rat",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo PET analysis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.8,
      "evidence": "in vivo PET analysis of [11C]-DTBZ binding",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "[11C]-DTBZ",
      "attributes": {},
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.9,
      "evidence": "[11C]-DTBZ binding",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 imaging with DTBZ",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "mast cell VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.8,
      "evidence": "mast cell VMAT2",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "altered DTBZ binding",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.75,
      "evidence": "Altered [11C]-DTBZ may reflect changes",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "changes in endogenous catecholamine levels",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.7,
      "evidence": "changes in endogenous catecholamine levels",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "altered VMAT2 protein expression or trafficking",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "confidence": 0.7,
      "evidence": "altered VMAT2 protein expression or trafficking",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 binding sites",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TBZ binding",
      "attributes": {
        "target_type": "binding_site"
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.9,
      "evidence": "TBZ binding",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.85,
      "evidence": "drug addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.8,
      "evidence": "in vitro",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "clinical studies",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.75,
      "evidence": "clinical studies",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "preclinical studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.7,
      "evidence": "preclinical studies",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "competitive inhibition",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.8,
      "evidence": "competitive inhibition of TBZ binding",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "dynamic regulation of VMAT2 expression",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "confidence": 0.7,
      "evidence": "VMAT2 protein expression is dynamically regulated",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.9,
      "evidence": "DAT was highly regulated",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 expression and transport activity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.85,
      "evidence": "drugs such as COC",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.85,
      "evidence": "drugs such as COC and AMPH",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "reserpine",
      "attributes": {},
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.9,
      "evidence": "profound depletion of brain monoamines with reserpine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "TBZ",
      "attributes": {},
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.85,
      "evidence": "TBZ binding",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Wilson and Kish 1988",
      "attributes": {
        "year": 1988,
        "design": "chronic treatment study"
      },
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.8,
      "evidence": "Wilson and Kish found no alteration",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "confidence": 0.75,
      "evidence": "chronically treated with COC",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "postmortem analysis of human striatal tissue",
      "attributes": {
        "design": "postmortem analysis",
        "sample_source": "human striatal tissue from chronic COC or METH users"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.85,
      "evidence": "postmortem analysis of human striatal tissue",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "postmortem human tissue analysis",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.8,
      "evidence": "postmortem analysis of human striatal tissue",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "striatal DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.9,
      "evidence": "striatal DA was depleted",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2 levels were affected",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "chronic COC use",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.85,
      "evidence": "chronic COC users",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "chronic METH use",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.85,
      "evidence": "chronic METH users",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "depletion of striatal DA",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.9,
      "evidence": "striatal DA was depleted",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "decrease in VMAT2 levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "confidence": 0.85,
      "evidence": "VMAT2 levels were affected in chronic COC (17\u201322% decrease)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is clearly required",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.9,
      "evidence": "reverse transport through DAT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.95,
      "evidence": "AMPH release of DA",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.95,
      "evidence": "COC action likewise requires",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "rewarding pharmacological effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.85,
      "evidence": "rewarding pharmacological effects",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "abuse liability",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.8,
      "evidence": "abuse liability",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "release of DA from synapses",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.85,
      "evidence": "AMPH release of DA from synapses",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "inhibition of DA reuptake",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.85,
      "evidence": "inhibiting DA reuptake through DAT",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "increased VMAT2 Vmax and Bmax",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.8,
      "evidence": "COC administration increased VMAT2 Vmax and Bmax",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "decreased VMAT2 Vmax and Bmax",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.8,
      "evidence": "AMPH administration decreased VMAT2 Vmax and Bmax",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "elevated VMAT2 density",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.75,
      "evidence": "COC treatment elevates VMAT2 density",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "increased cytoplasmic DA",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.8,
      "evidence": "AMPH increases cytoplasmic DA",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "decreased cytoplasmic DA",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.8,
      "evidence": "COC decreases cytoplasmic DA",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Fleckenstein et al.",
      "attributes": {
        "year": "recent",
        "design": "rodent study"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.7,
      "evidence": "Fleckenstein et al., based on their observations",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Schwartz et al.",
      "attributes": {
        "year": "recent",
        "design": "rat study"
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.7,
      "evidence": "Schwartz et al. have also reported",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Wilson and Kish",
      "attributes": {
        "design": "quantitative autoradiography",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.65,
      "evidence": "Wilson and Kish obtained via quantitative autoradiography",
      "verified": false
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "imaging literature",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "confidence": 0.75,
      "evidence": "consensus developed in the imaging literature",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Sabban et al., in press, 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.9,
      "evidence": "Sabban et al., in press, 2010",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.8,
      "evidence": "in vivo following immobilization stress",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 is up-regulated",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "up-regulation of VMAT2",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.85,
      "evidence": "VMAT2 is up-regulated",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Barr et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.9,
      "evidence": "Barr and co-workers have observed",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "developmental study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.8,
      "evidence": "developmentally dependent aversion learning",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.9,
      "evidence": "DAT and VMAT2 expression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "up-regulation of DAT and VMAT2",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.85,
      "evidence": "increases in both DAT and VMAT2 expression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "aldehyde dehydrogenase 1a1",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "confidence": 0.85,
      "evidence": "aldehyde dehydrogenase 1a1",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "f087a6d56245d6726368c459b103dc65"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopaminergic neurons",
      "attributes": {
        "target_type": "neuronal population"
      },
      "source_chunk_ids": [
        "f087a6d56245d6726368c459b103dc65"
      ],
      "confidence": 0.85,
      "evidence": "dopaminergic neuronal population",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "rewarding effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f087a6d56245d6726368c459b103dc65"
      ],
      "confidence": 0.8,
      "evidence": "rewarding effects of drugs of abuse",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "neurotransmitter availability",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "f087a6d56245d6726368c459b103dc65"
      ],
      "confidence": 0.75,
      "evidence": "neurotransmitter availability in nerve",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Lohoff et al. 2006",
      "attributes": {
        "year": 2006,
        "doi": "10.1038/sj.npp.1301199"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "Lohoff FW, et al. Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology. 2006; 31:2739\u20132747.",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "genetic association study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.85,
      "evidence": "Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter",
        "gene_symbol": "SLC18A1"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.95,
      "evidence": "vesicular monoamine transporter 1 gene (VMAT1/SLC18A1)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "bipolar I disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "associated with bipolar i disorder",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Chu & Liu 2010",
      "attributes": {
        "year": 2010,
        "doi": "10.1038/jhg.2010.23"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "Chu TT, Liu Y. An integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes. J Hum Genet. 2010; 55:285\u2013292.",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "genomic analysis",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.85,
      "evidence": "integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "schizophrenia susceptibility genes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Lin et al. 2005",
      "attributes": {
        "year": 2005,
        "doi": "10.1093/hmg/ddi154"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "Lin Z, et al. SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum Mol Genet. 2005; 14:1393\u20131404.",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "genetic association study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.85,
      "evidence": "SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "SLC18A2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.95,
      "evidence": "SLC18A2 promoter haplotypes",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "alcoholism",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "protective factor against alcoholism",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Lohoff et al. 2008",
      "attributes": {
        "year": 2008,
        "doi": "10.1016/j.neulet.2008.01.047"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "Lohoff FW, et al. Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits. Neurosci Lett. 2008; 434:41\u201345.",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "genetic association study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.85,
      "evidence": "Association between variation in the vesicular monoamine transporter 1 gene and anxiety-related personality traits",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "anxiety-related personality traits",
      "attributes": {
        "condition_type": "trait"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "anxiety-related personality traits",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "The VMAT2 gene in mice and humans",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Uhl et al. 2000",
      "attributes": {
        "year": 2000,
        "doi": "10.1096/fj.00-0245com"
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.9,
      "evidence": "Uhl GR, et al. The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins. FASEB J. 2000; 14:2459\u20132476.",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "functional study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "confidence": 0.85,
      "evidence": "The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "vesicular monoamine transporter 2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "confidence": 0.9,
      "evidence": "inhibits VMAT2 function",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "UKCP-110",
      "attributes": {},
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "confidence": 0.95,
      "evidence": "UKCP-110 (cis-2,5-di-(2-Phenethyl)-pyrrolidine Hydrochloride)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "confidence": 0.9,
      "evidence": "methamphetamine-evoked",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibition of VMAT2 function",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "confidence": 0.85,
      "evidence": "inhibits VMAT2 function",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "vesicular monoamine transporter-2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.9,
      "evidence": "vesicular monoamine transporter-2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "dopamine transporter",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "vesicular monoamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "vesicular monoamine transporter",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "methamphetamine self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Methamphetamine Self-administration in Rats",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "schizophrenia spectrum disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "schizophrenia spectrum disorders",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "Parkinson disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Parkinson disease",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "Huntington's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Huntington's disease",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "hyperkinetic movement disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "hyperkinetic movement disorders",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Nickell et al. 2010",
      "attributes": {
        "year": 2010,
        "design": "experimental study"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.9,
      "evidence": "Nickell JR, et al. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. J Pharmacol Exp Ther. 2010",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Persico et al. 1995",
      "attributes": {
        "year": 1995,
        "design": "genetic study"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Persico AM, et al. Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders. Am J Med Genet. 1995",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Bohnen et al. 2006",
      "attributes": {
        "year": 2006,
        "design": "PET imaging study"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Bohnen NI, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Suzuki et al. 2001",
      "attributes": {
        "year": 2001,
        "design": "observational study"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.85,
      "evidence": "Suzuki M, et al. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse. 2001",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Jankovic 2009",
      "attributes": {
        "year": 2009,
        "design": "review"
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.7,
      "evidence": "inhibition of the vesicular monoamine transporter-2",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "genetic association study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.75,
      "evidence": "Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "PET imaging",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "Positron emission tomography of monoaminergic vesicular binding",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Evidence",
      "name": "observational study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.75,
      "evidence": "Vesicular neurotransmitter transporters in Huntington's disease",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 5
      },
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "confidence": 0.8,
      "evidence": "Treatment of hyperkinetic movement disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "vesicular monoamine transporter 2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.9,
      "evidence": "Vesicular Monoamine Transporter 2 (VMAT2)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.9,
      "evidence": "dopamine transporter",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "vesicular monoamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.85,
      "evidence": "vesicular monoamine transporter",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Anlauf M et al. 2006",
      "attributes": {
        "year": 2006,
        "design": "observational"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Anlauf M, et al. 2006",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Schmitt KC and Reith ME 2010",
      "attributes": {
        "year": 2010,
        "design": "review"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Schmitt KC, Reith ME. 2010",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Naudon L et al. 1996",
      "attributes": {
        "year": 1996,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Naudon L, et al. 1996",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Wilson JM and Kish SJ 1996",
      "attributes": {
        "year": 1996,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Wilson JM, Kish SJ. 1996",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Wilson JM et al. 1996 (chronic cocaine users)",
      "attributes": {
        "year": 1996,
        "design": "observational"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Wilson JM, et al. 1996",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Wilson JM et al. 1996 (chronic methamphetamine users)",
      "attributes": {
        "year": 1996,
        "design": "observational"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Wilson JM, et al. 1996",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Schwartz K et al. 2007",
      "attributes": {
        "year": 2007,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Schwartz K, et al. 2007",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Li H et al. 2005",
      "attributes": {
        "year": 2005,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.8,
      "evidence": "Li H, et al. 2005",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "J Histochem Cytochem",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "Ann N Y Acad Sci",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "Eur J Neurosci",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "J Neurosci",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "human observational",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "Ann Neurol",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "human observational",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "Nat Med",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "J Neural Transm",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "confidence": 0.7,
      "evidence": "Neuron",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "V-ATPase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "confidence": 0.9,
      "evidence": "proton pump (V-ATPase)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "VMAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "confidence": 0.9,
      "evidence": "transporter protein (VMAT)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "neurotransmitter accumulation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "confidence": 0.85,
      "evidence": "neurotransmitter accumulation in a synaptic vesicle",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "electrochemical proton gradient establishment",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "confidence": 0.8,
      "evidence": "electrochemical proton gradient",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "amine transport into vesicle",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "confidence": 0.8,
      "evidence": "one Amine+ molecule into the vesicle",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "hVMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "2def64e3a861ce17d5245774303c96f6"
      ],
      "confidence": 0.9,
      "evidence": "hVMAT1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "hVMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "2def64e3a861ce17d5245774303c96f6"
      ],
      "confidence": 0.9,
      "evidence": "hVMAT2",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "hVMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.9,
      "evidence": "Differential expression of hVMAT1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "hVMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.9,
      "evidence": "Differential expression of hVMAT2",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VMAT1",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.85,
      "evidence": "Staining for VMAT1",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.85,
      "evidence": "Staining for VMAT2",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Erickson et al.,32",
      "attributes": {
        "year": "32",
        "design": "microscopy study"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.8,
      "evidence": "Adrenal gland data are taken from Erickson et al.,32",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.7,
      "evidence": "staining and incubation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "expression in adrenal medulla",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.75,
      "evidence": "expression of both VMAT1 and VMAT2 in human adrenal medulla",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "absence in brain tissue",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "confidence": 0.75,
      "evidence": "complete absence of specific staining for VMAT1 in human brain tissue",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "confidence": 0.9,
      "evidence": "VMAT (Vesicular Monoamine Transporter)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "confidence": 0.9,
      "evidence": "DAT (Dopamine Transporter)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "confidence": 0.95,
      "evidence": "AMPH (amphetamine)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "confidence": 0.95,
      "evidence": "COC (cocaine)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "confidence": 0.9,
      "evidence": "DA (dopamine)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "VMAT2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "confidence": 0.95,
      "evidence": "VMAT2 trafficking, expression, and targeting",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "confidence": 0.9,
      "evidence": "site of action of AMPH at DAT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "AMPH",
      "attributes": {},
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "confidence": 0.9,
      "evidence": "Dual site of action of AMPH",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "COC",
      "attributes": {},
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "confidence": 0.9,
      "evidence": "single site of action of COC at DAT",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "TBZ",
      "attributes": {},
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "confidence": 0.9,
      "evidence": "TBZ binds directly to VMAT2",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.8,
      "evidence": "effects on DAT",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.8,
      "evidence": "effects on DAT",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "action": "targets"
      },
      "confidence": 0.75,
      "evidence": "VMAT2 as a target for AMPH",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "targets"
      },
      "confidence": 0.75,
      "evidence": "VMAT2 as a target for COC",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increase dopamine in the synapse",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increase dopamine in the synapse",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "rewarding actions of these drugs",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "rewarding actions of these drugs",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "addictive actions of these drugs",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "addictive actions of these drugs",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "context": "pharmacological",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "drugs of abuse",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "context": "pharmacological",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "drugs of abuse",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "context": "pharmacological",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "addiction",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {
        "context": "pharmacological",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "addiction",
      "source_chunk_ids": [
        "9682909beb68e91618f40a214ff673cd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "experiments established the first molecular link",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "reserpine",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "amphetamine [AMPH]",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "phenylephrine",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "ephedrine",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "characterized"
      },
      "confidence": 0.8,
      "evidence": "monoamine uptake into storage vesicles",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "block 14C-epinephrine uptake",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "linked"
      },
      "confidence": 0.7,
      "evidence": "psychotropic drug action",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.7,
      "evidence": "block 14C-epinephrine uptake",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.7,
      "evidence": "block 14C-epinephrine uptake",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.7,
      "evidence": "block 14C-epinephrine uptake",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.7,
      "evidence": "block 14C-epinephrine uptake",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "link between monoamine uptake and psychotropic drug action",
      "source_chunk_ids": [
        "1c98efc2d7efd08e7d2d01c21a4b6638"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "linked to susceptibility",
        "assertion": "suggests"
      },
      "confidence": 0.8,
      "evidence": "VMAT2 to schizophrenia",
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "linked to susceptibility",
        "assertion": "suggests"
      },
      "confidence": 0.8,
      "evidence": "VMAT1 linked to schizophrenia",
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "linked to susceptibility",
        "assertion": "suggests"
      },
      "confidence": 0.8,
      "evidence": "VMAT1 linked to bipolar depression",
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "protection from",
        "assertion": "suggests"
      },
      "confidence": 0.75,
      "evidence": "VMAT2 to protection from alcohol neurotoxicity",
      "source_chunk_ids": [
        "fc4ec07f33f510207d1151057c3f0288"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "binds",
        "measurement": null
      },
      "confidence": 0.7,
      "evidence": "ligand binding of dihydrotetrabenazine",
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT2 as a target for treatment of addiction",
      "source_chunk_ids": [
        "751ffd41157a45e761d1cd3e61c73ab2"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "peripheral",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT1 might play a role in peripheral adrenaline release",
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "context": "peripheral",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT2 might play a role in peripheral adrenaline release",
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Hansson et al. have reported VMAT1 mRNA expression",
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Hansson et al. have reported VMAT1 mRNA expression",
      "source_chunk_ids": [
        "636cec4a63f0f6c0fb329e31f6e3a48c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "VMAT1 is present in human brain tissue",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "abolished"
      },
      "confidence": 0.85,
      "evidence": "abolition of reserpine-sensitive monoamine uptake",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "VMAT1 is not expressed at appreciable levels",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "concordance between inheritance of VMAT1 alleles and schizophrenia",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "concordance between inheritance of VMAT1 alleles and affective disorders",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "studies have failed to substantiate",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "data relevant to drug addiction",
      "source_chunk_ids": [
        "0a0975abf476d4ec3bc70feec339ba02"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Chronic drug use... produce impairments in monoaminergic circuits",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Chronic drug use... include neurotoxicity",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Chronic drug use... enhanced sensitivity of receptor signaling",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "With continued drug use... depleted monoamine stores",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "impairments... include neurotoxicity",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "impairments... include... enhanced sensitivity",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "depleted monoamine stores... VMAT2 is likely to play a central role",
      "source_chunk_ids": [
        "2fbe5b60594cf0e239d1df363f2ee167"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "scavenge 5-HT to create serotonergic neurons",
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "5-HTT might be operative in mediating developmental effects",
      "source_chunk_ids": [
        "79b6b06862c42272eb094f0020ad5519"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "heterologous-cell 5-HT uptake assay",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "examined VMAT2 for various psychostimulants",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 2,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of d-amphetamine was 2 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 7,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of MDMA was 7 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 5,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of fenfluramine was 5 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 9,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of MPP+ was 9 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 1.4,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of dopamine was 1.4 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 0.9,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "in vitro"
        }
      },
      "confidence": 0.8,
      "evidence": "affinity for VMAT2 of 5-HT was 0.9 \u03bcM",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "implicated"
      },
      "confidence": 0.75,
      "evidence": "dopamine, the major neurotransmitter implicated in addiction",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.7,
      "evidence": "trigger addiction and/or hedonic reward",
      "source_chunk_ids": [
        "f7937ddee7a4bb22154d331591a2f3d9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts with",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "interactions between drug, DAT and VMAT2",
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "interacts with",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "interactions between drug, DAT and VMAT2",
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Vesicular amine depletion",
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Vesicular amine depletion",
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.55,
      "evidence": "process by which individuals become addicted",
      "source_chunk_ids": [
        "27ed4b6147441bed2fb677e96ad92e77"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "releases",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "affinity",
          "notes": "relative affinity of AMPH and HIS for VMAT2"
        }
      },
      "confidence": 0.75,
      "evidence": "AMPH and related compounds to release HIS from storage vesicles",
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.7,
      "evidence": "HIS-releasing action of addictive amine-releasing drugs",
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Duerr et al. have hypothesized",
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "hypothesized about VMAT2 evolution",
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.7,
      "evidence": "role in central neurochemistry of substance abuse and addiction",
      "source_chunk_ids": [
        "655463dfe0b7f68e0e9c80e404b4d470"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Synaptic efficacy is thought to be the cellular substrate for learning and memory",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "learning associated with addiction",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "activity-dependent changes in synaptic efficacy been sought and found in changes of synaptic scaling",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "changes in synaptic scaling involving altered vesicular (quantal) content",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "neurotransmitter quantal content might be a dynamically regulated physiological process",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "VACht were altered in vivo to affect quantal size",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "biosynthesis and vesicle filling, along with quantal release probability, could regulate the architecture of neurotransmission",
      "source_chunk_ids": [
        "e9e9b6f0cc366f92517a95206c30498a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Ueda laboratory study",
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "decreases quantal size",
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibitor of monoamine uptake by VMAT2",
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "inhibitor of monoamine uptake",
      "source_chunk_ids": [
        "047eafa0e1b2128112754e7301afcfc9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "series of papers",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E16",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "describe linkage between G-protein expression and vesicular filling by VMAT2",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E16",
      "target_entity_id": "E2",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "VMAT1 or VMAT2 expression",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.8,
      "evidence": "regulation of VMAT2 activity, and thus of vesicular filling",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.75,
      "evidence": "regulation of quantal size",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "uptake"
      },
      "confidence": 0.8,
      "evidence": "uptake of tritiated serotonin",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.75,
      "evidence": "modulated by previous store filling with unlabeled biogenic amine",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cocaine-induced behavioral sensitization",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "bidirectional": true
      },
      "confidence": 0.75,
      "evidence": "requires G-proteins",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "bidirectional": true
      },
      "confidence": 0.7,
      "evidence": "requires... the calcium-activated protein for secretion (CAPS)",
      "source_chunk_ids": [
        "99889004a570b3f0ee6b38128b415558"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "PKA signaling is reduced",
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "leads to",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT2 trafficking to SSVs",
      "source_chunk_ids": [
        "7a82bc9361c9908f67ed953dc0d5467f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "targets"
      },
      "confidence": 0.8,
      "evidence": "compounds targeting VMAT2, such as lobaline",
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "proposed"
      },
      "confidence": 0.7,
      "evidence": "may be useful in the treatment of methamphetamine addiction",
      "source_chunk_ids": [
        "b9b5f4f2fc5f612cd3f488e55aeddaf2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "knockout mice deficient in VMAT2 expression",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "knockout mice deficient in VMAT2 expression",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.85,
      "evidence": "Complete knockout (-/-) of VMAT2 expression is lethal at birth",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "accompanied by lack of feeding behavior",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "reduced total labeled monoamine accumulation",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.85,
      "evidence": "monoamine levels are profoundly reduced",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "action": "mimics",
        "notes": "partially rescues VMAT2 knockout lethality via indirect release"
      },
      "confidence": 0.7,
      "evidence": "can be partially rescued by administration of amphetamine",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits",
        "notes": "similar effect on monoamine accumulation as VMAT2 knockout"
      },
      "confidence": 0.7,
      "evidence": "levels found after reserpine administration",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "knockout"
      },
      "confidence": 0.75,
      "evidence": "Complete knockout (-/-) of VMAT2 expression is lethal at birth",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "knockout"
      },
      "confidence": 0.7,
      "evidence": "accompanied by lack of feeding behavior",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "knockout"
      },
      "confidence": 0.7,
      "evidence": "reduced total labeled monoamine accumulation",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "knockout"
      },
      "confidence": 0.75,
      "evidence": "monoamine levels are profoundly reduced",
      "source_chunk_ids": [
        "db627d67e7a0183783522d31b582b640"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "VMAT2 heterozygous mice demonstrate loss of DA and 5-HT",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "regulation of VMAT2 activity and/or expression",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "overexpression in neuroendocrine cell models",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "overexpression of VMAT2",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "confirms"
      },
      "confidence": 0.75,
      "evidence": "quantal size is a direct function of VMAT2 density",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "vesicular transport plays a role in sequestration",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "implications for neurodegeneration",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "Parkinson-like clinical outcomes",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "altered sensitivity in VMAT2-deficient mice",
      "source_chunk_ids": [
        "4da0392cde9a1ebd361f9537c7c070fe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Uhl and colleagues have reported",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "VMAT2-deficient mice",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "compound"
      },
      "confidence": 0.75,
      "evidence": "AMPH-induced",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "sensitization to AMPH-induced locomotion",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "decreased AMPH-induced reward",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "action": "modulates",
        "context": "deficiency alters sensitivity"
      },
      "confidence": 0.7,
      "evidence": "altered sensitivity to drugs of abuse conferred in VMAT2-deficient mice",
      "source_chunk_ids": [
        "ce59a9370fbaa5222b28621b2235396f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "VMAT2 SNPs linked to Parkinson's disease",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "VMAT2 haplotypes contributory to addiction",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT2 SNPs linked to neurodegeneration",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "VMAT2 SNPs linked to depression",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "VMAT2 SNPs linked to bipolar disease",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "VMAT2 SNPs linked to schizophrenia",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Heritability evidence for genetic component",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Twin concordance evidence for genetic component",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Case-control association evidence for disease phenotypes",
      "source_chunk_ids": [
        "1ed54094b42d9395a9aaa2d35d73d815"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "ruled out VMAT2 allelic variants as genetic contributors to schizophrenia risk",
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.8,
      "evidence": "identify VMAT2 as one of nine genes demonstrating a gene-function correlation in schizophrenia",
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.75,
      "evidence": "correlation between ethanol consumption in male mice and VMAT2 expression",
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.75,
      "evidence": "VMAT2-deficient mice show a decreased ethanol preference",
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "reduces_risk"
      },
      "confidence": 0.8,
      "evidence": "hVMAT2 SNP cluster defines a reduced risk for alcoholism",
      "source_chunk_ids": [
        "bd46ed89572b098e8b34ddf5481a7a81"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "work of Barr and colleagues",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.85,
      "evidence": "modulation of VMAT2 expression",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "modulation of VMAT2 expression",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "during the development of corticosterone-dependent aversion learning",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "context": "developmental"
      },
      "confidence": 0.7,
      "evidence": "during the development of corticosterone-dependent aversion learning",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive",
        "assertion": "refutes",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "alterations in VMAT2 expression during the acquisition of addictive behaviors... have not yet been reported",
      "source_chunk_ids": [
        "6ff1842e2be1ffe6d8c9d418b27065e2"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.85,
      "evidence": "VMAT2 binding characteristics",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": 0.09,
          "unit": "uM",
          "measurement_type": "affinity",
          "notes": "under initial-velocity uptake conditions"
        }
      },
      "confidence": 0.9,
      "evidence": "affinity of TBZ for VMAT2 is about 0.09 \u03bcM",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "treatment of hyperkinetic disorders including chorea associated with Huntington's disease",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "treatment of hyperkinetic disorders including Tourette's syndrome",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "action": "depletes"
      },
      "confidence": 0.85,
      "evidence": "dopamine-depleting properties",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.8,
      "evidence": "affinity for reserpine",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.7,
      "evidence": "affinities of NE for VMAT2",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.7,
      "evidence": "affinities of DA for VMAT2",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.7,
      "evidence": "affinities of 5-HT for VMAT2",
      "source_chunk_ids": [
        "a9345c7cac09b437c149fccdd1c00784"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds",
        "assertion": "refutes"
      },
      "confidence": 0.9,
      "evidence": "TBZ does not bind to hVMAT1",
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "affinity",
          "notes": "high affinity"
        }
      },
      "confidence": 0.85,
      "evidence": "high affinity for hVMAT2",
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.8,
      "evidence": "TBZ binding to VMAT2",
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "affinity",
          "notes": "relative affinity"
        }
      },
      "confidence": 0.75,
      "evidence": "high affinity for VMAT2 relative to DA",
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "in vivo",
        "notes": "sensitive to depletion during chronic AMPH usage",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "TBZ as an in vivo ligand could well be sensitive to chronic AMPH usage",
      "source_chunk_ids": [
        "c46cbf7a8973c85720a82e2343af91c0"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.85,
      "evidence": "DTBZ administration",
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "measure striatal [11C]-DTBZ binding",
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "pre-clinical and clinical PET studies",
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "measure striatal [11C]-DTBZ binding",
      "source_chunk_ids": [
        "24116453f3c0cbcf357ffe477da70718"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in vivo PET analysis",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "examined [11C]-DTBZ binding",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.9,
      "evidence": "VMAT2 imaging with DTBZ",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "Altered [11C]-DTBZ may reflect",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "reflect changes in endogenous catecholamine levels",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "or altered VMAT2 protein expression or trafficking",
      "source_chunk_ids": [
        "69bf4b4c950edb12cdf70c95adeacf66"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.85,
      "evidence": "VMAT2 binding sites",
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "competitive inhibition...alters TBZ binding",
      "source_chunk_ids": [
        "13e02b6199827a600f0340f747b7a4bd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "perturbs"
      },
      "confidence": 0.7,
      "evidence": "DAT was highly regulated by drugs such as COC",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "perturbs"
      },
      "confidence": 0.7,
      "evidence": "DAT was highly regulated by drugs such as AMPH",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.8,
      "evidence": "reserpine binds irreversibly to the same site that TBZ occupies",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.8,
      "evidence": "TBZ occupies reversibly",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Wilson and Kish found no alteration",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "chronically treated with COC",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "found no alteration in TBZ binding site number (VMAT2 Bmax)",
      "source_chunk_ids": [
        "4846f2851f3b69ea0dbc589e0b0ffb77"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "postmortem analysis of human striatal tissue",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "depleted"
      },
      "confidence": 0.9,
      "evidence": "striatal DA was depleted",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "affected"
      },
      "confidence": 0.9,
      "evidence": "VMAT2 levels were affected",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "chronic COC users",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "chronic METH users",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.9,
      "evidence": "striatal DA was depleted",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observed",
        "measurement": {
          "value": 17,
          "unit": "%",
          "measurement_type": "decrease",
          "notes": "range 17\u201322% decrease in chronic COC users"
        }
      },
      "confidence": 0.85,
      "evidence": "17\u201322% decrease",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "chronic COC users had striatal DA depletion",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "chronic COC users had VMAT2 decrease",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "chronic METH users had striatal DA depletion",
      "source_chunk_ids": [
        "c0b18125f5d38ff208057335d12b72f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "requires"
      },
      "confidence": 0.85,
      "evidence": "AMPH release of DA requires action at VMAT2",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "action": "requires"
      },
      "confidence": 0.85,
      "evidence": "COC action requires exocytotic release through VMAT2",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "VMAT2 required for rewarding effects of AMPH",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "VMAT2 required for rewarding effects of COC",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "perhaps also for abuse liability",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "perhaps also for abuse liability",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "AMPH release of DA from synapses",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "COC action of inhibiting DA reuptake",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "inhibiting DA reuptake through DAT",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "COC administration increased VMAT2 Vmax and Bmax",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "AMPH administration decreased VMAT2 Vmax and Bmax",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "COC treatment elevates VMAT2 density",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_change",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "VMAT2 density did not change",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "based on observations",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reported",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "obtained via quantitative autoradiography",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "AMPH increases cytoplasmic DA",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "COC decreases cytoplasmic DA",
      "source_chunk_ids": [
        "4cc8165ab0a662866faf5a99862aa7fb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vivo following immobilization stress",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "VMAT2 is up-regulated",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "VMAT2 is up-regulated",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "developmentally dependent aversion learning",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "DAT and VMAT2 expression",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "DAT and VMAT2 expression",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "increases in both DAT and VMAT2 expression",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "aldehyde dehydrogenase 1a1",
      "source_chunk_ids": [
        "d720ed14a6e293617ffcb0b689acc029"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "functional relationship between... neurotransmitter availability and rewarding effects",
      "source_chunk_ids": [
        "f087a6d56245d6726368c459b103dc65"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "vesicular monoamine transporter 1 gene (VMAT1/SLC18A1)",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "associated with bipolar i disorder",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "schizophrenia susceptibility genes",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "SLC18A2 promoter haplotypes",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "protective"
      },
      "confidence": 0.85,
      "evidence": "protective factor against alcoholism",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Association between variation in the vesicular monoamine transporter 1 gene and anxiety-related personality traits",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "vesicular monoamine transporter 1 gene",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "anxiety-related personality traits",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "The VMAT2 gene in mice and humans",
      "source_chunk_ids": [
        "5103ef7c49158963c9b9d8347e61e849"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibits VMAT2 function",
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "inhibits VMAT2 function",
      "source_chunk_ids": [
        "74019239687680ba1df5e34544163fb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "inhibition of the vesicular monoamine transporter-2",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Positron emission tomography of monoaminergic vesicular binding",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Vesicular neurotransmitter transporters in Huntington's disease",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Treatment of hyperkinetic movement disorders",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "inhibition"
      },
      "confidence": 0.9,
      "evidence": "inhibition of the vesicular monoamine transporter-2",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "no_linkage"
      },
      "confidence": 0.8,
      "evidence": "Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "binding_changes"
      },
      "confidence": 0.85,
      "evidence": "Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observations"
      },
      "confidence": 0.85,
      "evidence": "Vesicular neurotransmitter transporters in Huntington's disease",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "treatment_review"
      },
      "confidence": 0.8,
      "evidence": "Treatment of hyperkinetic movement disorders",
      "source_chunk_ids": [
        "15301970d21ba7c9e224ee0491fc4d91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "J Histochem Cytochem",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Ann N Y Acad Sci",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Eur J Neurosci",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "J Neurosci",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Ann Neurol",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Nat Med",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "J Neural Transm",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Neuron",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "VMAT2 Expression in Hematopoietic Cells",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "Regulation of the dopamine transporter",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "vesicular monoamine transporter and di-hydrotetrabenazine binding",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "Striatal dopamine, dopamine transporter, and vesicular monoamine transporter",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "Striatal dopamine nerve terminal markers",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "elevates"
      },
      "confidence": 0.8,
      "evidence": "Cocaine, but not amphetamine, short term treatment elevates the density of rat brain VMAT2",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway",
      "source_chunk_ids": [
        "632285a471646cb156e378c0cb9b57a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "pumps H+"
      },
      "confidence": 0.85,
      "evidence": "pump H+ into the vesicle",
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "drives exchange"
      },
      "confidence": 0.8,
      "evidence": "driven by the electrochemical proton gradient",
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "facilitates exchange"
      },
      "confidence": 0.85,
      "evidence": "facilitates the exchange of two H+ ions out for one Amine+ molecule into the vesicle",
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "contributes to accumulation"
      },
      "confidence": 0.75,
      "evidence": "neurotransmitter accumulation in a synaptic vesicle",
      "source_chunk_ids": [
        "39b7937af35bf0b036d858efd48f308e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "staining and incubation as described in Ref. 32",
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "detected"
      },
      "confidence": 0.75,
      "evidence": "Staining for VMAT1",
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "detected"
      },
      "confidence": 0.75,
      "evidence": "Staining for VMAT2",
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "expression of both VMAT1 and VMAT2 in human adrenal medulla",
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "complete absence of specific staining for VMAT1 in human brain tissue",
      "source_chunk_ids": [
        "514077703c7d8b38f133a3dc413cc30b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "acts on"
      },
      "confidence": 0.8,
      "evidence": "AMPH acting on VMAT",
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "acts on"
      },
      "confidence": 0.8,
      "evidence": "AMPH acting on DAT",
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "COC inhibiting DAT",
      "source_chunk_ids": [
        "0b4e628ea645e52755547e5830e12812"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "acts on"
      },
      "confidence": 0.85,
      "evidence": "site of action of AMPH at DAT",
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "acts on"
      },
      "confidence": 0.85,
      "evidence": "site of action of COC at DAT",
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.9,
      "evidence": "TBZ binds directly to VMAT2",
      "source_chunk_ids": [
        "a0e031d3b585bf2e65b8b8df3c51f817"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}